Certified Global Research Member
Key Questions Answered
- Global Market Outlook
- In-depth analysis of global and regional trends
- Analyze and identify the major players in the market, their market share, key developments, etc.
- To understand the capability of the major players based on products offered, financials, and strategies.
- Identify disrupting products, companies, and trends.
- To identify opportunities in the market.
- Analyze the key challenges in the market.
- Analyze the regional penetration of players, products, and services in the market.
- Comparison of major players’ financial performance.
- Evaluate strategies adopted by major players.
- Recommendations
Why Choose Market Research Future?
- Vigorous research methodologies for specific market.
- Knowledge partners across the globe
- Large network of partner consultants.
- Ever-increasing/ Escalating data base with quarterly monitoring of various markets
- Trusted by fortune 500 companies/startups/ universities/organizations
- Large database of 5000+ markets reports.
- Effective and prompt pre- and post-sales support.
Deformity market covers the spectrum of musculoskeletal disorders which include congenital deformities, deformities caused by injury or disease, and deformities that occur with age, like osteoarthritis. Market dynamics are determined by the frequency and intensity of those diseases among various populations.
Variants of therapy for musculoskeletal deformations depend on that kind as well as the stage of the disease. In mild deformities, nonoperative measures, i.e., physical therapy and bracing are advised, and in moderate to severe deformities, operative measures, i.e., corrective osteotomy and joint replacement are to be considered.
Orthopedic implants evolution including custom implants and 3D printing brings personalized therapy for difficult musculoskeletal deformities. The new technologies bring the market dynamics because they provide more individual approaches.
The deformity market can be categorized into several classes such as the deformity type- spinal deformities (scoliosis, kyphosis), limb deformities, joint deformities. Each part provides a variety of concrete issues and viewpoints to the medical device manufacturers, healthcare providers, and other stakeholders.
The economic costs of musculoskeletal deformities as an economic burden include costs of healthcare for diagnosis, treatment, rehab, and indirect costs due to loss of productivity aftermath of disability. Economic factors dictate the market dynamics such as pricing strategies and reimbursement policies.
The approval processes and commercialism of orthopedic devices and surgical treatments for musculoskeletal deformities are governed by the regulatory agencies such as the FDA in USA and EMA in Europe. Compliance with regulatory requirements is the condition for entering the market and answers the general market attitude.
Deformity market is a stressful market as there are many players including medical device companies, orthopedic surgeons and rehabilitation specialists. Product innovation, market penetration, and alliances are some of the determinants of market dynamics.
Technological breakthroughs like robotic-assisted surgery and navigation systems are changing the scenario of deformity management with the improvement of surgical accuracy and outcomes. The innovations progress the market dynamics by enhancing the efficacy and efficiency of the treatment options.
Some of the causes of investment in research and development projects for musculoskeletal deviations are market forces, technological advances and government aids. Financing of innovations in the deformity market is provided by government organizations, venture capital firms, and nonprofit institutions.
Deformity Market Highlights:
Deformity Market Scenario
The global deformity market is projected to reach USD 1,185.33 Million by 2030 at 7.8% CAGR during the forecast period 2022-2030.Deformity is the malformation of any component of the body leading to an impairment or functional loss of the organ. The condition results in the bony alteration in the topography of soft tissues. The exact cause for the disease is still unknown. However, genetic mutation, damage during the foetal stage, complications at birth, hormonal disorder, arthritis along with other causes are expected to cause this disease. Increasing prevalence of deformity is the major driving factor for the growth of the market. According to the Physicians Committee (2015), approximately 3% of all children born in the U.S. suffer major malformations at birth. Additionally, over 150,000 babies are born each year with birth defects. Though, in early stages the disease is acute, however if the proper treatment is not taken it may led to serious conditions. A number of diagnostic procedures are available in the market for the diagnosis of deformities. A number of companies are involved in the manufacturing of innovative and effective treatment options for the patients. Besides, the increasing government support and rising healthcare expenditure are also supporting the growth of the market. Furthermore, rapid development in the imaging technology and continuous improvement in the medical services have fuelled the market growth. As there is no precise treatment available in the market and the cost associated with the surgeries is very high which is not affordable for people in the developing regions. Thus, lack of the precise treatment and high cost of surgeries may slow the growth of the market. Â Â
Figure 1:- Global Deformity market share, by region (%) 
Sources: WHO, annual reports, press release, white paper, and company presentation
Â
Deformity Market Segmentation
The global deformity market is segmented on the basis of types, therapy and end users.
On the basis of types, the market is segmented into congenital, and acquired. Congenital deformity is further segmented into Sprangel’s shoulder, elbow joint congenital dislocation, and others.
On the basis of therapy, the market is the market is segmented into diagnosis and treatment. Diagnosis is further segmented into MRI, CT scan, bone scan and others. Treatment is further categorized into medical therapy, surgical therapy, postoperative care, long-term monitoring and others.
On the basis of end users, the market is segmented into hospital & clinics, orthopedic care centers and others.Â
Regional Analysis
The Americas dominates the global deformity market owing to large patient population. According to the Physicians Committee (2015), approximately 3% of all children born in the U.S. have a major malformation at birth. Increasing number of people suffering from deformity and other bones disease have driven the growth of the Americas deformity market. Additionally, increasing government support for research & development, availability of funds for research, and high per capita income will fuel the growth of the market. Increasing awareness among people regarding the disease and well-developed technology will create opportunities for the development of the market.
Europe accounts for the second leading deformity market, which is followed by Asia Pacific. Increasing patient population, availability of funds for research, and government support for research & development projected to drive the market in Europe. Germany, France and U.K is expected to lead the European market.
Asia Pacific is the fastest growing region in the global deformity market owing to rapidly increasing population, the developing economies and rising demand for the better treatment options for the diseases. India and China holds the major share of the market.
Whereas, the Middle East & Africa owns the least share of the global deformity market due to the presence of poor economy, especially, in the Africa region. The market of this region is dominated by the Middle East due to a well-developed healthcare sector and huge healthcare expenditure. However, Africa region shows the fastest growth for the market.Â
Key players in global deformity market
The major key players in the global deformity market: SpineCraft, LCC (U.S.), DePuy Synthes (U.S.), NuVasive (U.S.), OrthoPediatrics Corp. (U.S.), 3M (U.S.), Bristol-Myers Squibb and Company (U.S.), B. Braun (Germany), Stryker Corporation (U.S.), Pfizer Inc. (U.S.), Lineage Medical, Inc. (U.S.), Johnson & Johnson Services Inc. (U.S.), Argon Medical Devices, Inc (the Netherlands), and Cook Medical (U.S.).
Intended Audience
- Biotechnological institutes
- Pharmaceutical companies
- Government and Private Laboratories
- Research and Development (R&D) Companies
- Market Research and Consulting Service Providers
- Medical Research Laboratories
Research Methodology
Sources: WHO, annual reports, press release, white paper, and company presentation
Leading companies partner with us for data-driven Insights
Kindly complete the form below to receive a free sample of this Report
Tailored for You
- Dedicated Research on any specifics segment or region.
- Focused Research on specific players in the market.
- Custom Report based only on your requirements.
- Flexibility to add or subtract any chapter in the study.
- Historic data from 2014 and forecasts outlook till 2040.
- Flexibility of providing data/insights in formats (PDF, PPT, Excel).
- Provide cross segmentation in applicable scenario/markets.
